Last update :
03/02/2026
References   References 3129  
Type : Manufacturer

Research teams :
Authors :
Title : Irinotécan (Campto®) – Résumé des caractéristiques du produits
Reference : Pfizer 2008

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionIrinotecan Anticancer drug
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% mg/ml 30°C
3 Day
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% mg/ml 5°C Not specified
28 Day
Stability in solutions Polyvinyl chloride Glucose 5% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyvinyl chloride Glucose 5% mg/ml 30°C
3 Day
Stability in solutions Polyvinyl chloride Glucose 5% mg/ml 5°C Not specified
28 Day
Stability in solutions Polyethylene Sodium chloride 0,9% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyethylene Sodium chloride 0,9% mg/ml 30°C
3 Day
Stability in solutions Polyethylene Sodium chloride 0,9% mg/ml 5°C Not specified
28 Day
Stability in solutions Polyethylene Glucose 5% mg/ml 30°C Protect from light
28 Day
Stability in solutions Polyethylene Glucose 5% mg/ml 30°C
3 Day
Stability in solutions Polyethylene Glucose 5% mg/ml 5°C Not specified
28 Day
Compatible + Sodium chloride 0,9%
Compatible + Glucose 5%

  Mentions Légales